IGH(immunoglobulin heavy locus) 转至新版数据库

基因简称(symbol)
    [HGNC]     [GeneCards]     [NCBI]
基因种类(locus group)
同源简称(alias symbol)
基因家族代码(gene_family_id)
    [HGNC]     [GenScript]
omim代码
entrez码
    [Vega]
vega基因码
ensembl基因码
    [Ensembl]
基因家族(gene family)
refseq数据库代号

更多...

基因种类(locus_type)
基因名称状态(status)
location_sortable
同源基因名称(alias name)
基因名称批准使用时间(date_approved_reserved)
基因简称更名时间(date_symbol_changed)
基因名称更名时间(date_name_changed)
更新时间(date_modified)
ucsc码
ena
ccds数据码
uniprot数据码
pubmed代码
mgd码
rgd码
生命科学数据库(lsdb)
更新时间(date modified)
cosmic
mirbase
基因曾用简称(prev symbol)
基因曾用名称(prev name)
homeodb
cosmic
snornabase
bioparadigms slc
orphanet
假基因信息(pseudogeneorg)
horde id
merops
imgt
iuphar
kznf基因类别
mamit-trnadb
cd
LncRNA数据库
酶代码
中间纤维数据库

收起

14q32.33
基因染色体位置图

Immunoglobulins recognize foreign antigens and initiate immune responses such as phagocytosis and the complement system. Each immunoglobulin molecule consists of two identical heavy chains and two identical light chains. This region represents the germline organization of the heavy chain locus. The locus includes V (variable), D (diversity), J (joining), and C (constant) segments. During B cell development, a recombination event at the DNA level joins a single D segment with a J segment; this partially rearranged D-J gene is then joined to a V segment. The rearranged V-D-J is then transcribed with the IGHM constant region; this transcript encodes a mu heavy chain. Later in development B cells generate V-D-J-Cmu-Cdelta pre-messenger RNA, which is alternatively spliced to encode either a mu or a delta heavy chain. Mature B cells in the lymph nodes undergo switch recombination, so that the V-D-J gene is brought in proximity to one of the IGHG, IGHA, or IGHE genes and each cell expresses either the gamma, alpha, or epsilon heavy chain. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase, and by somatic hypermutation, which occurs during B cell maturation in the spleen and lymph nodes. Due to polymorphism, the numbers of functional V, J, and D genes differ among individuals and some V, D, J, and C segments may be pseudogenes. [provided by RefSeq, Oct 2013]

[中文简述(自动翻译):]  免疫球蛋白识别外来抗原,并启动免疫反应,如吞噬作用和补体系统。每个免疫球蛋白分子包含两个相同的重链和两条相同的轻链组成。这个区域表示的重链基因座的种系组织。轨迹包括V(可变的),D(多样性),J(连接),和C(常数)段。在B细胞发育,在DNA水平上一个重组事件加入与J区段的单个D区段;那么这部分重排D-J基因加入到一个V形段。重排的V-D-J的然后用IGHM恒定区转录;这份成绩单编码亩重链。以后开发的B细胞产生V-D-J-CMU-Cdelta前信使RNA,这是选择性剪接来编码任一亩或增量重链。成熟B细胞在淋巴结经受转换重组,从而使V-D-J基因被带到接近的IGHG,IGHA或IGHE基因之一并且每个细胞表达任一γ,α或ε重链。有几个J片段许多个别V段的重组提供了多种抗原识别。额外的多样性是由连接多样性达到,从随机附加由终端脱氧核苷酸转移酶的核苷酸所得,并通过体细胞突变,这在脾和淋巴结B细胞成熟过程中发生。由于多态性,官能Ⅴ的数,J和D基因的个体和一些V,D,J之间不同,和C链段可以是假基因。 [由RefSeq的,2013年10月提供]

IGH基因的碱基序列:[NCBI]
IGH基因的碱基突变:          

IGH基因在不同组织中的表达:    [UniProt]

基因在不同组织中的表达图
正向引物序列
正向引物Tm值
反向引物序列
反向引物Tm值
rank
      尚未收录相关数据

IGH基因(以及对应的蛋白质)的细胞分布位置:

[UniProt]     [GenomeNet]

Extracellular space Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi Apparatus Nucleus Mitochondrion 0 1 2 3 4 5 Confidence
  • 溶酶体
  • 内涵体
  • 细胞核
  • 细胞质
  • 液泡
  • 细胞膜
  • 细胞外基质
  • 内质网
  • 线粒体
  • 高尔基体
  • 细胞骨架

IGH基因的本体(GO)信息:

基因与其他基因之间的相互作用关系图
序号 作用方式 资源库来源/分值 基因名称 基因名称

可能调控IGH基因的相关microRNA:     


通路基因列表
疾病名称 关系值 NofPmids NofSnps 来源
疾病名称 关系值 NofPmids NofSnps 来源
Lymphoma, Follicular 0.138206468 49 0 BeFree_LHGDN_ORPHANET
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse 0.129771907 36 0 BeFree_ORPHANET
Alzheimer's Disease 0.12 1 1 GWASCAT
LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 3 0.12 0 0 ORPHANET
Chronic Lymphocytic Leukemia 0.03548294 123 0 BeFree_GAD
Lymphoma 0.02282098 66 1 BeFree_LHGDN
Multiple Myeloma 0.017925095 56 0 BeFree_LHGDN
B-Cell Lymphomas 0.017110769 53 0 BeFree_LHGDN
Precursor Cell Lymphoblastic Leukemia Lymphoma 0.014959098 28 0 BeFree_LHGDN
Mucosa-Associated Lymphoid Tissue Lymphoma 0.012506189 28 0 BeFree_LHGDN
Acute lymphocytic leukemia 0.010586233 39 0 BeFree
Neoplasm, Residual 0.00868614 32 0 BeFree
Diffuse Large B-Cell Lymphoma 0.005157396 19 0 BeFree
leukemia 0.004614512 17 0 BeFree
Precursor B-cell lymphoblastic leukemia 0.003800186 14 0 BeFree
MULTICYSTIC RENAL DYSPLASIA, BILATERAL 0.003257302 12 0 BeFree
Congenital chromosomal disease 0.002985861 11 0 BeFree
Hepatitis 0.00272435 1 0 LHGDN
Thrombocythemia, Essential 0.00272435 1 0 LHGDN
Infection 0.00272435 1 0 LHGDN
Waldenstrom Macroglobulinemia 0.002442977 9 1 BeFree
Trisomy 12 0.002442977 9 0 BeFree
Chromosome Aberrations 0.002367032 1 0 GAD
Burkitt Lymphoma 0.002171535 8 0 BeFree
Myeloid Leukemia, Chronic 0.002171535 8 0 BeFree
Pituitary dwarfism 0.001900093 7 0 BeFree
Lymphoproliferative Disorders 0.001900093 7 0 BeFree
Malignant lymphoma - lymphoplasmacytic 0.001900093 7 0 BeFree
Lymphoid leukemia 0.001628651 6 0 BeFree
Trisomy 0.001628651 6 0 BeFree
Leukemia, Myelocytic, Acute 0.001357209 5 0 BeFree
Leukemia, Plasma Cell 0.001357209 5 0 BeFree
Monoclonal Gammopathy of Undetermined Significance 0.001357209 5 0 BeFree
Leukemogenesis 0.001357209 5 0 BeFree
Hairy Cell Leukemia 0.001085767 4 0 BeFree
Leukemia, Lymphocytic, Acute, L1 0.001085767 4 0 BeFree
Lymphoma, Non-Hodgkin 0.001085767 4 0 BeFree
Monosomy 0.001085767 4 0 BeFree
Stereotypic Movement Disorder 0.001085767 4 0 BeFree
Ki-1+ Anaplastic Large Cell Lymphoma 0.001085767 4 0 BeFree
Splenic Marginal Zone B-Cell Lymphoma 0.001085767 4 0 BeFree
Gastric Mucosa-Associated Lymphoid Tissue Lymphoma 0.001085767 4 0 BeFree
Blast Phase 0.000814326 3 0 BeFree
Angioimmunoblastic Lymphadenopathy 0.000814326 3 0 BeFree
Lymphoma, Large-Cell, Follicular 0.000814326 3 0 BeFree
Immunoblastic Large-Cell Lymphoma 0.000814326 3 0 BeFree
Complete trisomy 18 syndrome 0.000814326 3 0 BeFree
Intraocular Lymphoma 0.000814326 3 0 BeFree
Gastric lymphoma 0.000814326 3 0 BeFree
Hyperdiploid B Acute Lymphoblastic Leukemia 0.000814326 3 0 BeFree
Plasmablastic lymphoma 0.000814326 3 0 BeFree
Autoimmune hemolytic anemia 0.000542884 2 0 BeFree
Ataxia Telangiectasia 0.000542884 2 0 BeFree
Dwarfism 0.000542884 2 0 BeFree
Gastritis 0.000542884 2 0 BeFree
Hepatitis C 0.000542884 2 0 BeFree
Hodgkin Disease 0.000542884 2 0 BeFree
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 0.000542884 2 0 BeFree
Leukemia, T-Cell 0.000542884 2 0 BeFree
Lymphocytosis 0.000542884 2 0 BeFree
T-Cell Lymphoma 0.000542884 2 0 BeFree
Peripheral T-Cell Lymphoma 0.000542884 2 0 BeFree
Chronic gastritis 0.000542884 2 0 BeFree
Hodgkin's disease, nodular sclerosis (clinical) 0.000542884 2 0 BeFree
Pseudolymphoma 0.000542884 2 0 BeFree
Primary central nervous system lymphoma 0.000542884 2 0 BeFree
Histiocytic sarcoma 0.000542884 2 0 BeFree
Adult Acute Lymphocytic Leukemia 0.000542884 2 0 BeFree
Small Lymphocytic Lymphoma 0.000542884 2 0 BeFree
Mature B-Cell Non-Hodgkin Lymphoma 0.000542884 2 0 BeFree
Gastric Diffuse Large B-Cell Lymphoma 0.000542884 2 0 BeFree
Marginal Zone B-Cell Lymphoma 0.000542884 2 0 BeFree
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 0.000542884 2 0 BeFree
Leukemia, B-Cell 0.000542884 2 0 BeFree
Aplastic Anemia 0.000271442 1 0 BeFree
Constitutional Symptom 0.000271442 1 0 BeFree
Craniosynostosis 0.000271442 1 0 BeFree
Diabetes Mellitus, Insulin-Dependent 0.000271442 1 0 BeFree
Diarrhea 0.000271442 1 0 BeFree
Eosinophilia 0.000271442 1 0 BeFree
Exanthema 0.000271442 1 0 BeFree
Failure to Thrive 0.000271442 1 0 BeFree
HIV Infections 0.000271442 1 0 BeFree
Immunoproliferative Small Intestinal Disease 0.000271442 1 0 BeFree
Kartagener Syndrome 0.000271442 1 0 BeFree
Lyme Disease 0.000271442 1 0 BeFree
Reticulosarcoma 0.000271442 1 0 BeFree
Multiple Sclerosis 0.000271442 1 0 BeFree
orbit (eye disorders) 0.000271442 1 0 BeFree
Epstein-Barr Virus Infections 0.000271442 1 0 BeFree
Primary Sj�gren's syndrome 0.000271442 1 0 BeFree
Multiple tumors 0.000271442 1 0 BeFree
Lymphoid interstitial pneumonia 0.000271442 1 0 BeFree
Laron Syndrome 0.000271442 1 0 BeFree
Malignant lymphomatous polyposis 0.000271442 1 0 BeFree
Angioendotheliomatosis 0.000271442 1 0 BeFree
Hematologic Neoplasms 0.000271442 1 0 BeFree
Immunoglobulin G2 deficiency 0.000271442 1 0 BeFree
Hepatitis C, Chronic 0.000271442 1 0 BeFree
Composite Lymphoma 0.000271442 1 0 BeFree
Progressive Neoplastic Disease 0.000271442 1 0 BeFree
Spots on skin 0.000271442 1 0 BeFree
Monocytoid B-cell lymphoma 0.000271442 1 0 BeFree
Precursor B-lymphoblastic lymphoma 0.000271442 1 0 BeFree
Growth failure 0.000271442 1 0 BeFree
Pituitary hypoplasia 0.000271442 1 0 BeFree
Plasma cell dyscrasia 0.000271442 1 0 BeFree
Langerhans Cell Sarcoma 0.000271442 1 0 BeFree
Follicular non-Hodgkin's lymphoma, large cell 0.000271442 1 0 BeFree
Primary Effusion Lymphoma 0.000271442 1 0 BeFree
Mediastinal (Thymic) Large B-Cell Lymphoma 0.000271442 1 0 BeFree
Eosinophilic disorder 0.000271442 1 0 BeFree
AIDS-Related Plasmablastic Lymphoma 0.000271442 1 0 BeFree
Classical Hodgkin's Lymphoma 0.000271442 1 0 BeFree
Colon Mucosa-Associated Lymphoid Tissue Lymphoma 0.000271442 1 0 BeFree
Small Lymphocytic Lymphoma with Plasmacytoid Differentiation 0.000271442 1 0 BeFree
Sporadic Burkitt's lymphoma 0.000271442 1 0 BeFree
Low Grade B-Cell Non-Hodgkin's Lymphoma 0.000271442 1 0 BeFree
Disorder characterized by eosinophilia 0.000271442 1 0 BeFree
Primary Lung Lymphoma 0.000271442 1 0 BeFree
Malformations of Cortical Development, Group II 0.000271442 1 0 BeFree
CAMPOMELIC DYSPLASIA 0.000271442 1 0 BeFree
Lymphoma, Follicular, Grade 3 0.000271442 1 0 BeFree
Plasmablastic Lymphoma of the Oral Mucosa 0.000271442 1 0 BeFree
Progressive cGVHD 0.000271442 1 0 BeFree
Allergic disposition 0.000271442 1 0 BeFree
Lymphoma, Diffuse 0.000271442 1 0 BeFree
我要说两句
热门评论
还没有评论,赶快来抢沙发吧。

登陆

用户名:

密    码:

联系方式

山东省济南市 高新区 崇华路359号 三庆世纪财富中心C1115室

电话: 0531-88819269

E-mail: product@genelibs.com

微信公众号

扫一扫右方二维码,关注微信订阅号,实时查看信息,关注医学生物学动态。